In a Renal & Urology News story highlighting a novel polygenic risk score that may be useful for identifying men on active surveillance for prostate cancer, Mark Garzotto, M.D., says personalized approaches to active surveillance promise improvement in clinical outcomes while reducing health care expenditures; however, the risk score does not have a defined role in active surveillance.

A multi-institutional team of scientists developed a free, publicly accessible resource to aid in the classification of patient tumor samples. Kyle Ellrott, Ph.D., says: “A major element of this effort was working to ensure that these models could be deployed by other groups onto new datasets. All too often this type of work is difficult to replicate or apply to new samples.”

A multi-institutional team of scientists developed a free, publicly accessible resource to aid in the classification of patient tumor samples. Kyle Ellrott, Ph.D., says: “A major element of this effort was working to ensure that these models could be deployed by other groups onto new datasets. All too often this type of work is difficult to replicate or apply to new samples.”

A multi-institutional team of scientists developed a free, publicly accessible resource to aid in the classification of patient tumor samples. Kyle Ellrott, Ph.D., says: “A major element of this effort was working to ensure that these models could be deployed by other groups onto new datasets. All too often this type of work is difficult to replicate or apply to new samples.”

Dr. Dan Hoover, the Director of the Addiction Medicine ECHO Program, leads a jail-based ECHO program designed to improve treatment in Oregon county jails, like the Jackson County Jail.

Shivaani Kummar, M.D., is among the Portland Business Journal's 2025 “Women of Influence." The annual awards recognize women in Oregon and Southwest Washington for achievements in business, nonprofits and the public sector.

OHSU researchers identify how various delivery routes for AAV capsids reach kidney cells differently, paving the way for more effective treatments. Hiroyuki Nakai, M.D., Ph.D., says, “There was a misconception based on the literature already out there that AAV doesn’t work well on the kidney. Our study shows that we can deliver genes to renal tubules and podocytes in the kidney, the two important target cell types for gene therapy, and while there is a significant barrier, we now know that it is possible, especially for certain types of kidney diseases."

The Daily Astorian covers a $100,000 grant to expand the Clatsop Community College nursing program, which is part of the Oregon Consortium for Nursing Education, a partnership between nine Oregon community colleges and six OHSU campuses. The partnership gives students the opportunity to go on to earn their bachelor’s degree online through OHSU after graduating from community college.

The OHSU-Legacy Health integration is mentioned in an opinion column published in the Columbia County Spotlight and other Pamplin Media newspapers.

A mother whose son suffers from the rare disease PKAN says she connected with Susan Hayflick, M.D., whose research has helped advance PKAN understanding and treatments. Allison Gregory, M.S., says, “Sherine did an amazing job finding a suitable partnership that brings us closer to a cure for PKAN."